Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Missouri Technology Corporation provides strategic investments and leadership to foster the growth of high-tech businesses in Missouri—especially those focused on biosciences and advanced manufacturing. Through its IDEA Fund programs and grants like TechLaunch, it has invested over $53 million into more than 160 early-stage technology-focused companies since its inception. These portfolio companies have collectively raised over $1.6 billion in additional private capital since 2018[2]. Recent investments include startups developing cancer therapies, cell therapy delivery technologies, diagnostics for kidney function monitoring, and animal health products[6][10].
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Missouri Technology Corporation.